Form 8-K - Current report:
SEC Accession No. 0001104659-20-067501
Filing Date
2020-05-29
Accepted
2020-05-29 12:15:15
Documents
13
Period of Report
2020-05-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021315-1_8k.htm   iXBRL 8-K 56133
  Complete submission text file 0001104659-20-067501.txt   299769

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrk-20200526.xsd EX-101.SCH 4497
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20200526_def.xml EX-101.DEF 29639
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20200526_lab.xml EX-101.LAB 39097
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20200526_pre.xml EX-101.PRE 28248
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2021315-1_8k_htm.xml XML 8750
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 20925510
SIC: 2834 Pharmaceutical Preparations